Skip to content
Inciteful Med

The Biology of GPA: A System Out of Balance

Last updated:

Granulomatosis with polyangiitis (GPA) is an autoimmune disease where faulty B cells produce PR3-ANCA antibodies. These antibodies mistakenly activate neutrophils to attack small blood vessels, causing inflammation and forming small inflammatory masses called granulomas.

Key Takeaways

  • • GPA is an autoimmune condition where the immune system mistakenly attacks the body's own small blood vessels.
  • • The disease is driven by malfunctioning B cells that produce PR3-ANCA autoantibodies, which inappropriately activate neutrophil immune cells.
  • • A hallmark of GPA is the formation of granulomas, which are small collections of inflammatory cells.
  • • GPA frequently causes lung nodules that can mimic the appearance of cancer or infections on imaging scans.
  • • A biopsy is usually required to definitively diagnose GPA by identifying granulomas and vessel inflammation under a microscope.

To understand Granulomatosis with polyangiitis (GPA), it helps to look at it as a “case of mistaken identity” within your immune system. While a healthy immune system uses specialized cells to fight off bacteria and viruses, in GPA, those same cells turn their weapons against your own blood vessels [1][2].

The Biological “Chain Reaction”

The process that causes GPA involves three main players: B cells, neutrophils, and PR3-ANCA [3][4].

  1. B Cells (The Factory): B cells are a type of white blood cell that normally makes antibodies to protect you [5]. In GPA, some B cells malfunction and begin producing autoantibodies—antibodies that attack the self [3][4].
  2. PR3-ANCA (The Faulty Key): The most common autoantibody in GPA is called PR3-ANCA [6][7]. Think of this as a “faulty key” that fits into a lock on the surface of your neutrophils [4][8].
  3. Neutrophils (The Activated Soldiers): Neutrophils are your body’s first responders to infection [4]. When PR3-ANCA binds to them, it accidentally “flips the switch” to the ON position [4][8]. These activated neutrophils then stick to the walls of your small blood vessels, releasing toxic enzymes and “nets” of DNA that cause inflammation and damage to the vessel walls (vasculitis) [4][8][9].

The “Granuloma” Difference

The word “granulomatosis” refers to granulomas—small, ball-like collections of inflammatory cells that form when the immune system tries to “wall off” a perceived threat [10][11]. These granulomas are a hallmark of GPA and help distinguish it from other similar conditions [11][12].

GPA vs. Its “Cousins” (MPA and EGPA)

GPA belongs to a family called ANCA-associated vasculitis (AAV) [11][9]. It has two close relatives that can look similar but behave differently:

Feature GPA (Granulomatosis with Polyangiitis) MPA (Microscopic Polyangiitis) EGPA (Eosinophilic Granulomatosis with Polyangiitis)
Main Antibody Usually PR3-ANCA [6] Usually MPO-ANCA [6] Often MPO-ANCA (or none) [13]
Granulomas Yes (the hallmark) [11] No [14] Yes (contain eosinophils) [15]
Key Distinctions Frequent ENT/Sinus issues [16] Mostly affects kidneys/lungs [9] Asthma and high eosinophils [14]

Why GPA Mimics Other Diseases

Because GPA causes lung nodules (solid lumps of inflammation), it is very frequently mistaken for other conditions on imaging like X-rays or CT scans [17][11]:

  • Mistaken for Cancer: On a scan, a GPA nodule can look identical to a tumor [17][18].
  • Mistaken for Infection: Because these nodules can “cavitate” (hollow out in the center), they often look like tuberculosis or a fungal infection [17][19].

To tell the difference, doctors often need a biopsy—a small tissue sample—to look for the tell-tale granulomas and vessel inflammation under a microscope [17][20]. Understanding this biology helps explain why your treatment focuses on “calming down” your B cells and neutrophils to stop the damage at its source [3][5].

Frequently Asked Questions

What role does PR3-ANCA play in GPA?
PR3-ANCA is an autoantibody produced by malfunctioning B cells. It acts like a faulty key that mistakenly activates your neutrophils, causing them to attack and inflame the walls of your small blood vessels.
What are granulomas?
Granulomas are small, ball-like collections of inflammatory cells that form when the immune system tries to wall off a perceived threat. They are a hallmark feature of GPA and help doctors distinguish it from other forms of vasculitis.
Why are GPA lung nodules sometimes mistaken for cancer or infection?
GPA causes solid lumps of inflammation called lung nodules. On X-rays and CT scans, these nodules can look identical to lung tumors or hollow out in the center, making them look like tuberculosis or fungal infections.
What is the difference between GPA and MPA?
While both are types of ANCA-associated vasculitis, GPA is characterized by granulomas and often involves sinus and ENT issues. MPA typically lacks granulomas and is more likely to primarily affect the kidneys and lungs.
Why do I need a biopsy to diagnose GPA?
To confirm a GPA diagnosis and rule out cancer or infection, doctors often need to take a biopsy. Examining this small tissue sample under a microscope allows them to look for the tell-tale granulomas and blood vessel inflammation.

Questions for Your Doctor

  • • Do I have PR3-ANCA or MPO-ANCA, and how does that affect my long-term treatment and risk of a flare?
  • • If my lung nodules look like infection or cancer, how can we be sure they are caused by GPA?
  • • How do my B cells and neutrophils play a role in my specific case, and how does my medication target them?
  • • Does my biopsy show the 'granulomas' that distinguish GPA from other types of vasculitis?
  • • If I have asthma-like symptoms, could my diagnosis actually be EGPA?

Questions for You

  • • Have I ever been diagnosed with asthma or told I have high 'eosinophil' levels in my blood?
  • • When I look at my lab results, do I see 'PR3' or 'c-ANCA' mentioned?
  • • Am I able to explain the basic 'biological breakdown' of my disease to a family member or friend?
  • • How has understanding the biology of GPA changed how I feel about my diagnosis?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Granulomatosis With Polyangiitis: A Clinical Case.

    Rodrigues F, Oliveira Sá AI, Mendes M, et al.

    Cureus 2022; (14(12)):e32410 doi:10.7759/cureus.32410.

    PMID: 36636531
  2. 2

    Therapeutic Complement Targeting in ANCA-Associated Vasculitides and Thrombotic Microangiopathy.

    Novikov P, Kozlovskaya N, Moiseev S, et al.

    Biomedicine hub 2016; (1(3)):1-11 doi:10.1159/000453106.

    PMID: 31988889
  3. 3

    Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis.

    Falde SD, Fussner LA, Tazelaar HD, et al.

    The Lancet. Rheumatology 2024; (6(5)):e314-e327 doi:10.1016/S2665-9913(24)00035-3.

    PMID: 38574742
  4. 4

    Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management.

    Ge S, Zhu X, Xu Q, et al.

    Frontiers in pharmacology 2022; (13()):957660 doi:10.3389/fphar.2022.957660.

    PMID: 36210838
  5. 5

    ANCA-Associated Vasculitis: Core Curriculum 2020.

    Geetha D, Jefferson JA

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2020; (75(1)):124-137 doi:10.1053/j.ajkd.2019.04.031.

    PMID: 31358311
  6. 6

    Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides.

    Wójcik K, Masiak A, Jeleniewicz R, et al.

    Polish archives of internal medicine 2022; (132(3)) doi:10.20452/pamw.16187.

    PMID: 34985235
  7. 7

    Type of ANCA May Be Indispensable in Distinguishing Subphenotypes of Different Clinical Entities in ANCA-Associated Vasculitis.

    Konstantouli AM, Lioulios G, Stai S, et al.

    Life (Basel, Switzerland) 2022; (12(10)) doi:10.3390/life12101467.

    PMID: 36294902
  8. 8

    [Update on etiopathogenesis of small vessel vasculitis].

    Arnold S, Holl-Ulrich K, Müller A, et al.

    Zeitschrift fur Rheumatologie 2022; (81(4)):270-279 doi:10.1007/s00393-021-01155-4.

    PMID: 35084556
  9. 9

    ANCA associated vasculitis (AAV): a review for internists.

    Yaseen K, Mandell BF

    Postgraduate medicine 2023; (135(sup1)):3-13 doi:10.1080/00325481.2022.2102368.

    PMID: 35831990
  10. 10

    [ANCA-Associated Vasculitides].

    Stegert M, Neumann T, Daikeler T

    Therapeutische Umschau. Revue therapeutique 2022; (79(5)):229-237 doi:10.1024/0040-5930/a001355.

    PMID: 35583025
  11. 11

    Granulomatosis With Polyangiitis (Wegener Granulomatosis): Then and Now.

    Churg A, Muller NL

    Archives of pathology & laboratory medicine 2025; (150(1)):37-43 doi:10.5858/arpa.2025-0146-RA.

    PMID: 41429180
  12. 12

    RITUXIMAB: THE DRUG THAT NEVER FAILS TO SURPRISE!

    Seth AA, Patel S, Gangam MA, Hayat SQ

    The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society 2015; (167(3)):153.

    PMID: 27159476
  13. 13

    Anti-neutrophil cytoplasmic antibodies and their clinical significance.

    Suwanchote S, Rachayon M, Rodsaward P, et al.

    Clinical rheumatology 2018; (37(4)):875-884 doi:10.1007/s10067-018-4062-x.

    PMID: 29525845
  14. 14

    A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.

    Quan MV, Frankel SK, Maleki-Fischbach M, Tan LD

    BMC pulmonary medicine 2018; (18(1)):181 doi:10.1186/s12890-018-0733-2.

    PMID: 30497438
  15. 15

    [Granulomatous vasculitides and vasculitides with extravascular granulomatosis].

    Arnold S, Klapa S, Holl-Ulrich K, et al.

    Zeitschrift fur Rheumatologie 2022; (81(7)):558-566 doi:10.1007/s00393-022-01249-7.

    PMID: 35962194
  16. 16

    Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis Causes Aortic Valve Degeneration and Severe Aortic Regurgitation.

    Guterbaum TJ, Husic M, Voss A, Dahl JS

    The American journal of case reports 2019; (20()):423-429 doi:10.12659/AJCR.912693.

    PMID: 30930460
  17. 17

    New lung mass in a patient with granulomatosis with polyangiitis.

    Masiak A, Fijałkowska J, Nowakowski S, et al.

    Rheumatology international 2021; (41(2)):493-499 doi:10.1007/s00296-020-04646-w.

    PMID: 32671469
  18. 18

    [Pulmonar pseudotumor in granulomatosis with polyangiitis (GPA). Pulmonary cancer and/or GPA? Diagnostic implications of pulmonary nodules].

    Horta-Baas G, Meza-Zempoaltecatl E, Pérez-Cristóbal M, Barile-Fabris LA

    Gaceta medica de Mexico 2016; (152(4)):521-8.

    PMID: 27595257
  19. 19

    Thoracic Manifestations of ANCA-associated Vasculitis: Review of the 2022 American College of Rheumatology-European Alliance of Associations of Rheumatology Classification Criteria.

    Kwon J, Choi YW, Kim H, Yoo SJ

    Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(4)):e240089 doi:10.1148/rg.240089.

    PMID: 40146625
  20. 20

    Atypical Endobronchial Carcinoid with Postobstructive Pneumonia Obscuring the Diagnosis of Granulomatosis with Polyangiitis.

    Ali R, Baldeo C, Onyenekwe J, et al.

    Case reports in rheumatology 2015; (2015()):513602 doi:10.1155/2015/513602.

    PMID: 26347844

This page explains the biology of Granulomatosis with polyangiitis (GPA) for educational purposes only. Always consult your rheumatologist or healthcare provider to interpret your specific lab results and diagnosis.

Stay up to date

Get notified when new research about Granulomatosis with polyangiitis is published.

No spam. Unsubscribe anytime.